A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens-Reference-Cited by-同舟云学术

A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens

Published:1990-12 Issue:2 Volume:173 Page:534-540
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Veldscholte J.,Ris-Stalpers C.,Kuiper G.G.J.M.,Jenster G.,Berrevoets C.,Claassen E.,van Rooij H.C.J.,Trapman J.,Brinkmann A.O.,Mulder E.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. Gene regulation by steroid hormones

2. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

3. Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens

Cited by 875 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308;Oncology Reports;2024-08-07

2. Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

3. Androgen receptor-dependent mechanisms mediating therapy resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024

4. Deciphering the genetic and epigenetic architecture of prostate cancer;Advances in Cancer Research;2024

5. Breaking through resistance in mCRPC: Enzalutamide analogues as effective anticancer agents for enhanced male survival;Results in Chemistry;2023-12